References
- Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–700.
- Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
- Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
- Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.
- Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211–5.
- Belzil VV, St-Onge J, Daoud H, Desjarlais A, Bouchard JP, Dupre N, et al. Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis. J Hum Genet. 2011;56:247–9.
- DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
- Nelson LM. Epidemiology of ALS. J Clin Neurosci. 1996; 3:327–31.
- Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144–52.
- Fang F, Kamel F, Sandler DP, Sparen P, Ye WM. Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2008;167:1281–6.
- Soriani MH, Desnuelle C. Epidemiology of amyotrophic lateral sclerosis. Rev Neurol. 2009;165:627–40.
- Wolfson C, Kilborn S, Oskoui M, Genge A. Incidence and Prevalence of Amyotrophic Lateral Sclerosis in Canada: A Systematic Review of the Literature. Neuroepidemiology. 2009;33:79–88.
- Svenson LW, Cwik VA, Martin WR. The prevalence of motor neurone disease in the Province of Alberta. Can J Neurol Sci. 1999;26:119–22.
- Table 051-0001. Estimates of population, by age group and gender for July 1, Canada, provinces. and territories, annual (persons unless otherwise noted) (Internet). Statistics Canada. (cited 2012-05-25).
- Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157–9
- Eisen A, Mezei MM, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethics issues in management. Amyotroph Lateral Scler. 2008;9:108–19.
- Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol. 1998;57: 895–904.
- Lopate G, Baloh RH, Al-Lozi MT, Miller TM, Fernandes Filho JA, Ni O, et al. Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation. Amyotroph Lateral Scler. 2010;11:232–6.
- Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: a population based study. The South-East England Register for amyotrophic lateral sclerosis (SEALS registry). Neuroepidemiology. 2007;29:44–8.
- Chio A, Terreni A, Cucatto A, Calvo A, Bertolotto A, Bottacchi E, et al. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001; 56:239–44.
- Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurol. 2012;11:232–40.
- den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15:7–12.